InsiderClue
Insiders · Profile

Friedl-Naderer Johanna

Chief Commercial Officer at Dyne Therapeutics · EVP & Chief Operating Officer at Vir Biotechnology. Filing since 3 Mar 2023. CIK 0001915598

DYN Dyne Therapeutics, Inc. Chief Commercial Officer · 11 trades VIR Vir Biotechnology, Inc. EVP & Chief Operating Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
DYN Dyne Therapeutics, Inc.
8 Sep 2026
Chief Commercial Officer
Sold on a plan
185
$3.49K
0.1%
DYN Dyne Therapeutics, Inc.
4 Sep 2026
Chief Commercial Officer
Sold on a plan
900
$21.92K
0.6%
DYN Dyne Therapeutics, Inc.
13 Aug 2026
Chief Commercial Officer
Sold on a plan
226
$5.94K
0.1%
DYN Dyne Therapeutics, Inc.
16 Jun 2026
Chief Commercial Officer
Sold on a plan
145
$2.66K
0.1%
DYN Dyne Therapeutics, Inc.
13 May 2026
Chief Commercial Officer
Sold on a plan
228
$4.19K
0.1%
DYN Dyne Therapeutics, Inc.
5 Mar 2026
Chief Commercial Officer
Sold on a plan
148
$2.21K
0.1%
DYN Dyne Therapeutics, Inc.
5 Dec 2025
Chief Commercial Officer
Sold on a plan
144
$2.98K
0.2%
DYN Dyne Therapeutics, Inc.
5 Sep 2025
Chief Commercial Officer
Sold on a plan
144
$1.93K
0.2%
DYN Dyne Therapeutics, Inc.
4 Sep 2025
Chief Commercial Officer
Sold on a plan
894
$11.86K
0.9%
DYN Dyne Therapeutics, Inc.
5 Jun 2025
Chief Commercial Officer
Sold on a plan
146
$1.95K
0.2%
DYN Dyne Therapeutics, Inc.
13 Mar 2025
Chief Commercial Officer
Sold on a plan
143
$1.73K
0.1%
VIR Vir Biotechnology, Inc.
3 Mar 2023
EVP & Chief Operating Officer
Sold, plan not stated
1,482
$33.82K
1.0%
12 decisions on file.